These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 31512372

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
    Maminezhad H, Ghanadian S, Pakravan K, Razmara E, Rouhollah F, Mossahebi-Mohammadi M, Babashah S.
    Life Sci; 2020 Oct 01; 258():118226. PubMed ID: 32771555
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer.
    Xu L, Li M, Wang M, Yan D, Feng G, An G.
    BMC Cancer; 2014 Sep 25; 14():714. PubMed ID: 25255814
    [Abstract] [Full Text] [Related]

  • 7. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
    Imaoka H, Toiyama Y, Fujikawa H, Hiro J, Saigusa S, Tanaka K, Inoue Y, Mohri Y, Mori T, Kato T, Toden S, Goel A, Kusunoki M.
    Ann Oncol; 2016 Oct 25; 27(10):1879-86. PubMed ID: 27502702
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A panel of microRNA signature in serum for colorectal cancer diagnosis.
    Zhu M, Huang Z, Zhu D, Zhou X, Shan X, Qi LW, Wu L, Cheng W, Zhu J, Zhang L, Zhang H, Chen Y, Zhu W, Wang T, Liu P.
    Oncotarget; 2017 Mar 07; 8(10):17081-17091. PubMed ID: 28177881
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.
    Zekri AR, Youssef AS, Lotfy MM, Gabr R, Ahmed OS, Nassar A, Hussein N, Omran D, Medhat E, Eid S, Hussein MM, Ismail MY, Alenzi FQ, Bahnassy AA.
    PLoS One; 2016 Mar 07; 11(5):e0154130. PubMed ID: 27135244
    [Abstract] [Full Text] [Related]

  • 14. Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer.
    Ghanbari R, Mosakhani N, Asadi J, Nouraee N, Mowla SJ, Poustchi H, Malekzadeh R, Knuutila S.
    Cancer Biomark; 2015 Mar 07; 15(2):189-95. PubMed ID: 25519020
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O, Kara M, Yumrutas O, Bozgeyik E, Bozgeyik I, Celik OI.
    Tumour Biol; 2016 May 07; 37(5):6637-45. PubMed ID: 26643896
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.
    Luo X, Stock C, Burwinkel B, Brenner H.
    PLoS One; 2013 May 07; 8(5):e62880. PubMed ID: 23690963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.